Narhex Life Sciences Ltd is currently recruiting patients for a clinical trial of ResApp, the world’s first cough diagnosis smartphone app.

The app can reportedly diagnose whether a cough is a cold or flu symptom, uncomplicated residual bronchitis, or possibly indication of something more serious like chronic bronchitis, pneumonia or whooping cough that warrants further investigation, according to its developer.

The new trial will gather and analyze data from 150 subjects with a variety of respiratory conditions, with the objective to further optimize ResApp algorithms for pneumonia and asthma. The trial additionally aims to broaden the app’s validation if other common respiratory conditions such as bronchitis, bronchiolitis and upper respiratory tract conditions.

View the full story at